Dyslipidemia and its management after renal transplantation

Journal of Nephrology

Volumn 14, Issue 4 SUPPL., 2001, Pages

  Kasiske, Bertram L ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Chronic allograft nephropathy; Chronic rejection; HMG CoA reductase inhibitors; Hypercholesterolemia

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PREVALENCE; PROTEINURIA; REVIEW;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; PREVALENCE; PROTEINURIA;

EID: 0013419195     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 1998; 32 (suppl 3): S142-56.
2. Chatterjee SN, Chin HP, Azen SP, Blankenhorn DH, Boothe S, Massry SG. Abnormal serum lipid patterns in primary renal allograft recipients. Surgery 1977; 82: 655-9.